TRAF3 as a powerful and multitalented regulator of lymphocyte functions
- PMID: 27154354
- PMCID: PMC6608063
- DOI: 10.1189/jlb.2MR0216-063R
TRAF3 as a powerful and multitalented regulator of lymphocyte functions
Abstract
This review summarizes the current state of knowledge regarding the roles of the signaling adapter protein tumor necrosis factor receptor (TNFR)-associated factor 3 in regulating the functions of B and T lymphocytes. In B lymphocytes, TNFR-associated factor 3 inhibits signaling by TNFR superfamily receptors, Toll-like receptors, and interleukin-6R. In contrast, signaling to B cells by the virally encoded oncogenic protein latent membrane protein 1 is promoted by TNFR-associated factor 3. An important B cell-specific role for TNFR-associated factor 3 is the inhibition of homeostatic survival, directly relevant to the common occurrence of TNFR-associated factor 3 mutations in human B cell malignancies. TNFR-associated factor 3 was recently found to be a resident nuclear protein in B cells, where it interacts with and inhibits gene expression mediated by the cAMP response element-binding protein transcription complex, including expression of the prosurvival protein myeloid leukemia cell differentiation protein 1. In T lymphocytes, TNFR-associated factor 3 is required for normal signaling by the T cell antigen receptor, while inhibiting signaling by the interleukin-2 receptor. Cytoplasmic TNFR -associated factor 3 restrains nuclear factor-κB2 activation in both T and B cells. Clinical implications and future directions for the study of this context-dependent signaling regulator are discussed.
Keywords: B cell; T cell; signal transduction.
© Society for Leukocyte Biology.
Figures
Similar articles
-
Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.Cytokine Growth Factor Rev. 2014 Apr;25(2):147-56. doi: 10.1016/j.cytogfr.2013.12.002. Epub 2013 Dec 25. Cytokine Growth Factor Rev. 2014. PMID: 24433987 Free PMC article. Review.
-
Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.Immunol Rev. 2011 Nov;244(1):55-74. doi: 10.1111/j.1600-065X.2011.01055.x. Immunol Rev. 2011. PMID: 22017431 Free PMC article. Review.
-
Roles of TRAF3 in T cells: many surprises.Cell Cycle. 2015;14(8):1156-63. doi: 10.1080/15384101.2015.1021524. Cell Cycle. 2015. PMID: 25723057 Free PMC article. Review.
-
TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation.Front Immunol. 2018 Sep 24;9:2161. doi: 10.3389/fimmu.2018.02161. eCollection 2018. Front Immunol. 2018. PMID: 30319624 Free PMC article. Review.
-
Multiple roles of TRAF3 signaling in lymphocyte function.Immunol Res. 2007;39(1-3):22-32. doi: 10.1007/s12026-007-0068-1. Immunol Res. 2007. PMID: 17917053 Review.
Cited by
-
Identification of susceptibility loci and relevant cell type for IgA nephropathy in Han Chinese by integrative genome-wide analysis.Front Med. 2024 Oct;18(5):862-877. doi: 10.1007/s11684-024-1086-2. Epub 2024 Sep 30. Front Med. 2024. PMID: 39343836
-
TRAF3: Guardian of T lymphocyte functions.Front Immunol. 2023 Feb 6;14:1129251. doi: 10.3389/fimmu.2023.1129251. eCollection 2023. Front Immunol. 2023. PMID: 36814922 Free PMC article. Review.
-
TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells.Sci Rep. 2019 Sep 9;9(1):12884. doi: 10.1038/s41598-019-49390-9. Sci Rep. 2019. PMID: 31501481 Free PMC article.
-
TRAF family molecules in T cells: Multiple receptors and functions.J Leukoc Biol. 2020 Jun;107(6):907-915. doi: 10.1002/JLB.2MR1119-397R. Epub 2019 Nov 21. J Leukoc Biol. 2020. PMID: 31749173 Free PMC article. Review.
-
TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis.Nat Commun. 2019 Jun 26;10(1):2795. doi: 10.1038/s41467-019-10677-0. Nat Commun. 2019. PMID: 31243287 Free PMC article.
References
-
- Swain, S. L. , Dutton, R. W. (1987) Consequences of the direct interaction of helper T cells with B cells presenting antigen. Immunol. Rev. 99, 263–280. - PubMed
-
- Grewal, I. S. , Flavell, R. A. (1998) CD40 and CD154 in cell‐mediated immunity. Annu. Rev. Immunol. 16, 111–135. - PubMed
-
- Bishop, G. A. , Hostager, B. S. (2003) The CD40‐CD154 interaction in B cell‐T cell liaisons. Cytokine Growth Factor Rev. 14, 297–309. - PubMed
-
- Bishop, G. A. , Hostager, B. S. (2001) B Lymphocyte activation by contact‐mediated interactions with T lymphocytes. Curr. Opin. Immunol. 13, 278–285. - PubMed
-
- Bishop, G. A. , Haxhinasto, S. A. , Stunz, L. L. , Hostager, B. S. (2003) Antigen‐specific B‐lymphocyte activation. Crit. Rev. Immunol. 23, 149–197. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials